54 related articles for article (PubMed ID: 25369252)
1. [Relationship between hepatocellular carcinoma and the interaction between hMSH2 polymorphisms and environmental factors].
Tan S; Wang W; Liu S; Wei Q; Wei J; Wang Z; Yan M; Qiu X
Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):676-9. PubMed ID: 25369252
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors].
Tan SK; Qiu XQ; Tang GF; Wang WW; Liu S
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):833-7. PubMed ID: 23206302
[TBL] [Abstract][Full Text] [Related]
3. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract][Full Text] [Related]
4. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
6. [Study on the relationship between hepatocellular carcinoma and the interaction between polymorphisms in DNA repair gene XPD and environmental factors].
Zeng XY; Qiu XQ; Ji L; Yu HP
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):702-5. PubMed ID: 19957595
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
[TBL] [Abstract][Full Text] [Related]
9. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt.
Helal TE; Khamis NS; El-Sharkawy TM; Nada OH; Radwan NA
APMIS; 2010 Dec; 118(12):934-40. PubMed ID: 21091774
[TBL] [Abstract][Full Text] [Related]
11. [Study on the relationship between single-nucleotide polymorphisms in IL-6, IL-10 genes and HBV-related hepatocellular carcinoma].
Qiu XQ; Bei CH; Yu HP; Zeng XY; Zhong QA
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):510-3. PubMed ID: 21569738
[TBL] [Abstract][Full Text] [Related]
12. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
13. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
[TBL] [Abstract][Full Text] [Related]
14. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of STAT3 rs1053004 single nucleotide polymorphism in patients with chronic hepatitis B and hepatocellular carcinoma.
Fatemipour M; Arabzadeh SAM; Molaei H; Geramizadeh B; Dabiri S; Fatemipour B; Vahedi SM; Malekpour Afshar R
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):45-50. PubMed ID: 29307341
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between polymorphism of sex hormone binding globulin and occurrence of hepatocellular carcinoma].
Liu S; Qiu XQ; Zeng XY; Bai H; Xu Y; Zhang YY; Pan DX; Mao LQ; Huang QL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):538-42. PubMed ID: 22943902
[TBL] [Abstract][Full Text] [Related]
17. [Relation of polymorphisms of the XPD and GSTM1 genes with susceptibility to hepatocellular carcinoma in Qinghai Tibetans].
Zhao JH; Li H; Di J
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):831-6. PubMed ID: 25531380
[TBL] [Abstract][Full Text] [Related]
18. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.
Nan YL; Hu YL; Liu ZK; Duan FF; Xu Y; Li S; Li T; Chen DF; Zeng XY
World J Gastroenterol; 2016 Jun; 22(24):5558-67. PubMed ID: 27350734
[TBL] [Abstract][Full Text] [Related]
19. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
Yano M; Hamatani K; Eguchi H; Hirai Y; MacPhee DG; Sugino K; Dohi K; Itamoto T; Asahara T
Eur J Cancer; 2007 Apr; 43(6):1092-100. PubMed ID: 17350822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]